Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial

American Journal of Hematology

Volumn 88, Issue 11, 2013, Pages 932-938

  Alvarez, Ofelia ^a   Yovetich, Nancy A ^b   Scott, J Paul ^c   Owen, William ^d   Miller, Scott T ^e   Schultz, William ^f   Lockhart, Alexandre ^b   Aygun, Banu ^g   Flanagan, Jonathan ^h   Bonner, Melanie ⁱ   Mueller, Brigitta U ^h   Ware, Russell E ^f  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Rho Federal Systems Division Inc   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^e KINGS COUNTY HOSPITAL CENTER   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g Northwell Health   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFEROXAMINE; HEMOGLOBIN F; HYDROXYUREA;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHMA; BACTEREMIA; BLOOD TRANSFUSION; CATHETER COMPLICATION; CATHETER INFECTION; CEREBROVASCULAR ACCIDENT; CHELATION THERAPY; CHILD; CHOLECYSTITIS; CHOLELITHIASIS; CHOLESTASIS; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DISPERSIBLE TABLET; DRUG DOSE ESCALATION; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; GASTROENTERITIS; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; HYPERBILIRUBINEMIA; IMMUNE DEFICIENCY; INFECTION; IRON CHELATION; IRON OVERLOAD; KIDNEY DISEASE; KLEBSIELLA INFECTION; LEUKOCYTE COUNT; LONG TERM CARE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; MEGALOCYTOSIS; MUSCULOSKELETAL DISEASE; MYCOPLASMOSIS; NEUTROPENIA; PAIN; PHLEBOTOMY; PNEUMONIA; PRESCHOOL CHILD; PRIAPISM; PRIORITY JOURNAL; PYELONEPHRITIS; RETICULOCYTOPENIA; SCHOOL CHILD; SECONDARY PREVENTION; SEPTIC SHOCK; SICKLE CELL ANEMIA; SIDE EFFECT; STAPHYLOCOCCUS INFECTION; TACHYPNEA; THORAX PAIN; THROMBOCYTOPENIA; TRANSFUSION; UROSEPSIS; WHEEZING;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BENZOATES; BLOOD TRANSFUSION; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; HYDROXYUREA; INCIDENCE; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; PAIN MEASUREMENT; PHLEBOTOMY; RECURRENCE; STROKE; TRIAZOLES; YOUNG ADULT;

EID: 84886292309     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23547     Document Type: Article

References (21)

1. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
2. Lee MT, Piomelli S, Granger S, et al. Stroke prevention trial in sickle cell anemia (STOP): Extended follow-up and final results. Blood 2006;108:847-852.
3. Wang W. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol 2007;14:191-197.
4. Miller ST, Wright E, Abboud M, et al; STOP Investigators. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 2001;139:785-789.
5. Styles LA, Abboud M, Larkin S, et al. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol 2007;136:343-344.
6. Vichinsky EP, Ohene-Frempong K; transfusion committee. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: Results of an international survey. Pediatr Hematol Oncol 2011;28:37-42.
7. Bartolucci P, Chaar V, Picot J, et al. Decreased blood red cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation. Blood 2010;116:2152-2159.
8. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-1322.
9. Lanzkron S, Strouse JJ, Wilson R, et al. Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 2008;148:939-955.
10. Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001;97:3628-3632.
11. Steinberg MH, McCarthy WF, Castro O, et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow up. Am J Hematol 2010;85:403-408.
12. Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: A multicenter, randomised, controlled trial (BABY HUG). Lancet 2011;377:1663-1672.
13. Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 2004;145:346-352.
14. Ware RE, Helms RW; for the SWiTCH Investigators. Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood 2012;119:3925-3932.
15. Ware RE, Schultz WH, Yovetich N, et al. Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr Blood Cancer 2011;57:1011-1017.
16. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
17. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood 1995;86:778-783.
18. Frenette PS. Sickle cell vasoocclusion: Heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation 2004;11:167-177.
19. Vichinksy EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855-1865.
20. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-649.
21. Keidan AJ, Marwah SS, Vaughan GR, et al. Painful sickle cell crises precipitated by stopping prophylactic exchange transfusions. J Clin Pathol 1987;40:505-507.